Skip to main content
. 2019 Oct 18;11(10):1587. doi: 10.3390/cancers11101587

Figure 8.

Figure 8

Cyp2E1 and p47phox expression 24 h after combined sorafenib and SAHA treatment. (A) Cyp2E1 and (B) p47phox mRNA expression in HCC cells treated with sorafenib (Sora) and/or SAHA. Control cells (Ctr.) treated with solvent (DMSO) only were set at a value of 1. (*: p < 0.05).